Krissa Smith, Vice President of Mission Partnerships at Susan G. Komen, joins us to discuss the complexities of the BRCA gene and its impact on hereditary cancer risk. Krissa shares her family's experiences with genetic mutations, including the p53 gene, and explains the importance of genetic testing and how it can work in partnership with evolving cancer screening technology. Stay tuned for part 2 to learn more about genetics, cancer risk, and the importance of early detection.
Please take our survey to help us shape future episodes: https://bit.ly/3sQkbrN
Transcripts: https://grail.com/podcast/
Sign up for GRAIL’s newsletter: https://grail.com/newsletter-signup/